Utility of surveillance MRI in women with a personal history of breast cancer

Tadros, Audree B; Arditi, Brittany; Weltz, Christina; Port, Elisa; Margolies, Laurie; Schmidt, Hank

doi:10.1016/j.clinimag.2017.06.007

Cited by 11 publications

(4 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several previous investigations have demonstrated relatively consistent results, although the range in the reported data is somewhat broad and heterogeneous due to differences in patient selection, study design and applied MRI protocols (Table 4) [13,21,[28][29][30][31][32][33][34][35][36][37][38]. MRI showed higher incremental cancer yields (CDR, ranging from 3.8 to 118.1 per 1000 women) [13,21,[28][29][30][31][32][33][34][35][36][37][38], a high sensitivity of 75-100%, a high specificity of 82.2-98.3% [21,28,29,[31][32][33][34][35][36][37][38], a PPV1 of 5.3-20.3% and a PPV3 of 15.8-61.5% [21,28,29,[31][32][33][34][35][36]…”

Section: Discussionmentioning

confidence: 95%

Feasibility of abbreviated magnetic resonance imaging (AB-MRI) screening in women with a personal history (PH) of breast cancer

Kim

Kang

et al. 2020

PLoS ONE

View full text Add to dashboard Cite

To investigate the feasibility of abbreviated magnetic resonance imaging (AB-MRI) in women with a personal history (PH) of breast cancer as a screening tool. Materials and methods We retrospectively reviewed 1880 screening AB-MRIs in 763 women with a PH of breast cancer (median age, 55 years; range, 23-89 years) between October 2015 and October 2016. The total acquisition times of AB-MRI were 8.3 min and 2.8 min with and without T2weighted imaging, respectively. The tissue diagnosis or one-year follow-up status was used as the reference standard. The characteristics of tumor recurrences detected on AB-MRI screenings were analyzed. The cancer detection rates (CDRs) and additional CDRs for the 1 st round and overall rounds of AB-MRI screening were calculated. The recall rate, sensitivity, specificity, positive predictive values for recall (PPV1) and biopsy (PPV3) for the 1 st round of AB-MRI screening were calculated. The diagnostic performance of the combination of mammography and ultrasonography was compared with that of AB-MRI by receiver operating characteristic (ROC) curve analysis. Results Fifteen of a total of 21 recurrences were detected on the 1 st round of AB-MRI screening: 93.3% were node-negative T1 tumors (median tumor size, 1.02 cm; range, 0.1-2 cm) or Tis; 66.7% were high-grade tumors; 8 of these 15 were mammographically and ultrasonographically occult. The CDR and additional CDR for the 1 st round of AB-MRI screening were 0.019 and 0.010 per woman, respectively. The sensitivity, specificity, recall rate, PPV1 and PPV3 for the 1 st round of AB-MRI screening were 100%, 96.0%, 14.3%, 13.8% and 58.3%, respectively. For detecting secondary cancer, AB-MRI showed a higher sensitivity and PPV than the combination of mammography and ultrasonography (95.2%, 57.1% vs 47.6%, 38.5%). The area under the ROC curve was higher for AB-MRI (0.

show abstract

Section: Discussionmentioning

confidence: 95%

Feasibility of abbreviated magnetic resonance imaging (AB-MRI) screening in women with a personal history (PH) of breast cancer

Kim

Kang

et al. 2020

PLoS ONE

View full text Add to dashboard Cite

show abstract

“…Also women with a personal history of breast cancer have an elevated risk of breast cancer recurrence with a cumulative incidence of 5.4% in 5 years 61–63 . In recent years, the performance of the breast MRI as a screening imaging modality has been evaluated in these women 36,64–73 . The ACR recommends annual surveillance with breast MRI for women with a history of breast cancer since 2018 (Table 1).…”

Section: Literature Searchmentioning

confidence: 99%

“…[61][62][63] In recent years, the performance of the breast MRI as a screening imaging modality has been evaluated in these women. 36,[64][65][66][67][68][69][70][71][72][73] The ACR recommends annual surveillance with breast MRI for women with a history of breast cancer since 2018 (Table 1). 28 In Table 3, recent published studies assessing the performance of MRI in women with a personal history of breast cancer or familial cancer are reported.…”

Section: Women At High Risk For the Development Of Breast Cancermentioning

confidence: 99%

Challenges and Changes of the Breast Cancer Screening Paradigm

Cömert

Gils

Veldhuis

et al. 2022

Magnetic Resonance Imaging

View full text Add to dashboard Cite

Since four decades mammography is used for early breast cancer detection in asymptomatic women and still remains the gold standard imaging modality. However, population screening programs can be personalized and women can be divided into different groups based on risk factors and personal preferences. The availability of new and evolving imaging modalities, for example, digital breast tomosynthesis, dynamic‐contrast‐enhanced magnetic resonance imaging (MRI), abbreviated MRI protocols, diffusion‐weighted MRI, and contrast‐enhanced mammography leads to new challenges and perspectives regarding the feasibility and potential harms of breast cancer screening. The aim of this review is to discuss the current guidelines for different risk groups, to analyze the recent published studies about the diagnostic performance of the imaging modalities and to discuss new developments and future perspectives. Level of Evidence 1 Technical Efficacy Stage 6

show abstract

“…The targeted intervention included a letter and a booklet written at a seventh-grade reading level, which provided information about genetic counseling, cost, a list of certified cancer genetic services in Michigan, and online genetic resources. The booklet presented mammography screening as more sensitive than CBE and more accessible compared to MRI [30] and options for low cost screening. The targeted letter also included National Comprehensive Cancer Network (NCCN) guidelines for follow-up care (YBCS) and screening (relatives), and recommended that they seek genetic evaluation and breast surveillance/screening due to their own or their relative's early age of cancer onset.…”

Section: Interventionsmentioning

confidence: 99%

Genetic Testing and Surveillance of Young Breast Cancer Survivors and Blood Relatives: A Cluster Randomized Trial

Katapodi

Ming

Northouse

et al. 2020

Cancers

View full text Add to dashboard Cite

We compared a tailored and a targeted intervention designed to increase genetic testing, clinical breast exam (CBE), and mammography in young breast cancer survivors (YBCS) (diagnosed <45 years old) and their blood relatives. A two-arm cluster randomized trial recruited a random sample of YBCS from the Michigan cancer registry and up to two of their blood relatives. Participants were stratified according to race and randomly assigned as family units to the tailored (n = 637) or the targeted (n = 595) intervention. Approximately 40% of participants were Black. Based on intention-to-treat analyses, YBCS in the tailored arm reported higher self-efficacy for genetic services (p = 0.0205) at 8-months follow-up. Genetic testing increased approximately 5% for YBCS in the tailored and the targeted arm (p ≤ 0.001; p < 0.001) and for Black and White/Other YBCS (p < 0.001; p < 0.001). CBEs and mammograms increased significantly in both arms, 5% for YBCS and 10% for relatives and were similar for Blacks and White/Others. YBCS and relatives needing less support from providers reported significantly higher self-efficacy and intention for genetic testing and surveillance. Black participants reported significantly higher satisfaction and acceptability. Effects of these two low-resource interventions were comparable to previous studies. Materials are suitable for Black women at risk for hereditary breast/ovarian cancer (HBOC).

show abstract

Utility of surveillance MRI in women with a personal history of breast cancer

Cited by 11 publications

References 15 publications

Feasibility of abbreviated magnetic resonance imaging (AB-MRI) screening in women with a personal history (PH) of breast cancer

Feasibility of abbreviated magnetic resonance imaging (AB-MRI) screening in women with a personal history (PH) of breast cancer

Challenges and Changes of the Breast Cancer Screening Paradigm

Genetic Testing and Surveillance of Young Breast Cancer Survivors and Blood Relatives: A Cluster Randomized Trial

Contact Info

Product

Resources

About